MedPath

The effect of aerobic and resistance training on patients improved from COVID-19

Not Applicable
Conditions
COVID-19.
COVID-19 disease
U07.1
Registration Number
IRCT20220209053982N1
Lead Sponsor
Abadan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
33
Inclusion Criteria

People recovering from COVID-19
Women in the age range of 20 to 45 years
No other medical problems including cardiovascular disease, chronic liver, kidney, gastrointestinal disease, immune deficiency, chronic inflammatory disease and metabolic diseases
Lack of muscle, joint and orthopedic problems that prevent exercise

Exclusion Criteria

Pregnancy
Having been active in sports for the past year
taking medication

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Plasma levels of irisin. Timepoint: One day before the start of training protocols and forty-eight hours after the last training session. Method of measurement: Special irisin measurement kit.;Plasma levels of FGF21. Timepoint: One day before the start of training protocols and forty-eight hours after the last training session. Method of measurement: Special FGF21 measurement kit.;Plasma levels of folistatin. Timepoint: One day before the start of training protocols and forty-eight hours after the last training session. Method of measurement: Special follicatin measurement kit.
Secondary Outcome Measures
NameTimeMethod
Body mass index: It is a suitable measure for estimating the health of a person's weight according to height. Timepoint: Before and after the intervention. Method of measurement: By calculating height and weight.;Maximum oxygen consumption: is the maximum amount of oxygen consumed by a person per kilogram of body weight in one minute. Timepoint: Before and after the intervention. Method of measurement: Rockport Walk Test.
© Copyright 2025. All Rights Reserved by MedPath